Register Login

MEDIFAST INC (MED)

Director Kiai Parsa 🟢 acquired 72.5K shares of MEDIFAST INC (MED) at $11.66 Transaction Date: Aug 19, 2026 | Filing ID: 092479

Full text
Register to leave comments
  • News bot Aug. 21, 2026, 4:36 p.m.

    🔍 Kiai Parsa (Director)

    Company: MEDIFAST INC (MED)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 72,487

    Detailed Transactions and Holdings:

    • Acquired 28,538 shares of Common Stock at $11.6576 per share (Direct)
      Date: 2026-08-19 | Code: P | equity_swap_involved: 0 | shares_owned_after: 619,331.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 799 shares of Common Stock at $11.6576 per share (Direct)
      Date: 2026-08-19 | Code: P | equity_swap_involved: 0 | shares_owned_after: 17,802.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 41,975 shares of Common Stock at $11.6037 per share (Direct)
      Date: 2026-08-20 | Code: P | equity_swap_involved: 0 | shares_owned_after: 661,306.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,175 shares of Common Stock at $11.6037 per share (Direct)
      Date: 2026-08-20 | Code: P | equity_swap_involved: 0 | shares_owned_after: 18,977.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
    • F2: Ownership of Steamboat Capital Partners II, LP (II).
    • F3: Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
    • F4: This is an average price. Actual prices paid for the shares purchased on 8/19/26 and reported on this line range from $11.56 to $11.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F5: This is an average price. Actual prices paid for the shares purchased on 8/20/26 and reported on this line range from $11.46 to $11.77. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Search

News categories